Lipid lowering: education is key.
Fuster
Valentin
V
Mearns
Bryony M
BM
D056864:Behind-the-Counter Drugs / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003157:Community Pharmacy Services; D003257:Consumer Product Safety; D050171:Dyslipidemias / Q000150:complications / Q000628:therapy*; D019983:Guideline Adherence; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004366:Nonprescription Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D010353:Patient Education as Topic; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
D056864:Behind-the-Counter Drugs; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D004366:Nonprescription Drugs